The ruthenium complex with substituted imidazole ligand of formula [Ru(BIm) 2 (DMSO) 2 Cl 2 ].H 2 O (BIm=Benzimidazole) was prepared. The compound has been further characterized from spectroscopic data and elemental(C, H and N) analysis. The molecular structure of this compound was determined by single crystal X-ray diffraction study. Binding of this complex with plasmid-DNA was studied by UV-Visible and Emission spectral studies. Further electrochemical studies were performed to understand the DNA binding ability of this complex. The evidences of DNA binding were found from the change of the Intensity of fluorescence band and UV-band. Binding constant (K b ) calculated from UV-Spectroscopic titration is found to be 9.09 x 10 5 M -1 .
Introduction
The imidazole-metal complexes are important in medicine 1 and coordination chemistry 2 . The imidazole and DMSO ligands have been extensively used in many metal complexes 3 . We have synthesized a few benzimidazole ruthenium complexes which are found to be potent anticancer agent 4 . Ligand's effect on anticancer property 5 is important and it is essential to design superior complexes in terms of effectiveness compared to that which are already available agent such as cis-platin. The imidazole-metal complexes are important [6] [7] [8] [9] in medicine and coordination chemistry. The spectroscopy of these complexes in the absence and presence of plasmid DNA was examined and compared to cis-platin. Furthermore, benzimidazole complexes have been evaluated for antifungal activity and as antitumour agents 10, 11 . Hence, the imidazole and DMSO 12 ligands have been extensively used many metal complexes 13 .
RESEARCH ARTICLE
Benzimidazole cyclometalated complexes were found 14 to have good anticancer activity against HT29, T47D, A2780 and A2780cisR cancer cell lines 15, 16 . Representative complexes show high apoptosis, good accumulation and S-phase 17 cell arrest and strongly bind to HSA at sites I and II and also weakly bind to DNA at the minor groove 18 . Bis-benzimidazole bridged supramolecular coordination complex has potential to act as potent anticancer agents, particularly in cell lines which are resistant to Pt-based molecules 19, 20 . Further studies are under progress to investigate the biological mechanism of these derivatives 21 . We have synthesized few benzimidazole ruthenium complexes which are found to be potent anticancer agent 4, 22 . A single crystal X-ray diffraction study of this complex is reported.
Experimental
Analytical grade RuCl 3 .3H 2 O, Plasmid-DNA (pBR 322 DNA), Tris buffer were purchased from Sigma and Aldrich chemical companies, USA.
Characterization procedure
The IR Spectra of the compound was recorded as KBr pellets on a Perkin-Elmer FT-IR spectrophotometer. The UV-visible spectra were taken in a Shimadzu UV-2401 PC Spectrophotometer. 
Preparation

Synthesis of cis-dichlorobis-(benzimdazole)bis-(dimethylsulfoxide)ruthenium(II
Crystal structure
Fine crystals were mounted on glass capillary and data collected at room temperature. Data collection was carried out on a diffractometer (BRUKER SMART APEX2) using monochromated Mo Kα radiation. From the setting angles crystal dimension were determined. The structures ( Figure 1) were solved by the Patterson method. SHELXTL routine was used for empirical absorption correction. Experimental details are given in Table 1 . 
Results and Discussion
Spectroscopic studies on DNA binding: UV-Visible absorption titration
Interaction of the complexes with plasmid-DNA was monitored by UV-Visible absorption spectra of the complex at different concentration of DNA(2.289x10 -6 M to 9.089x10 -6 M). As the concentrations of the plasmid-DNA increased, red shift occurred from 351 nm to 359 nm and the absorbance decreases (Figure 2 ). The binding strength was estimated from the intrinsic binding constant, from the ratio of slope and intercept of the graph (Figure 3 ) from the following equation (1),
where ε a , ε f and ε b are the extinction coefficient of observed solution, free complex and the complex when it fully bound to plasmid-DNA respectively.
Fluorescence emission and quenching studies
Fluorescence study was perform in to phase, firstly keeping the concentration of metal complex constant and varying concentration of CT-DNA ( Figure 4 ) and secondly concentration of CT-DNA is fixed, and varying the concentration of metal complex ( Figure 5 ). Steady-state emission quenching experiments was performed using [Fe(CN) 6 ] 4− as quencher and the Stern-Volmer quenching constant (Ksv) was calculated by using Stern-Volmer equation 12 
Conclusion
The structural analysis was performed by single crystal XRD study, which shows six coordinated octahedral geometry. The results characterized by various techniques give evidences binding of the complex with plasmid-DNA. On the basis of spectroscopic shift, the intrinsic binding constant (K b ) is 9.09x10 5 M -1 . Emission quenching with [Fe(CN) 6 ] 4− in presence and absence of plasmid-DNA shows the Stern-volmer constant 33131 and 72079 respectively . Based on the observed distinct electrochemical E 1/2 and electrophoresis band shifts, the complex is expected to bind with plasmid-DNA.
